Patent details
EP2150249 Title: USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE
Basic Information
- Publication number:
- EP2150249
- PCT Application Number:
- PCT/US/2007/062241
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP077570596
- PCT Publication Number:
- WO/2007/095618
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE
- French Title of Invention:
- UTILISATION DE DÉRIVÉS DE SULFAMIDE À NOYAU HÉTÉROCYCLIQUE BENZOFUSIONNÉ POUR LE TRAITEMENT DE LA MIGRAINE
- German Title of Invention:
- VERWENDUNG VON BENZO-KONDENSIERTEN HETEROZYKLISCHEN SULFAMID-DERIVATEN ZUR BEHANDLUNG VON MIGRÄNE
- SPC Number:
Dates
- Filing date:
- 15/02/2007
- Grant date:
- 24/04/2013
- EP Publication Date:
- 24/04/2013
- PCT Publication Date:
- 23/08/2007
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/02/2010
- EP B1 Publication Date:
- 24/04/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/02/2014
- Expiration date:
- 15/02/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/02/2007
- Name:
- Janssen Pharmaceutica N.V.
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Inventor
- Name:
- SMITH-SWINTOSKY Virginia L.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 773764 P
- Priority Date:
- 15/02/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 674021
- Priority Date:
- 12/02/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/353;
| Filing date | Document type | Number of pages |
|---|